Mitochondria-Targeting, Intracellular Delivery of Native Proteins Using Biodegradable Silica Nanoparticles.

Mitochondria are key organelles in mammalian cells whose dysfunction is linked to various diseases. Drugs targeting mitochondrial proteins provide a highly promising strategy for potential therapeutics. Methods for the delivery of small-molecule drugs to the mitochondria are available, but these are not suitable for macromolecules, such as proteins. Herein, we report the delivery of native proteins and antibodies to the mitochondria using biodegradable silica nanoparticles (BS-NPs). The modification of the nanoparticle surface with triphenylphosphonium (TPP) and cell-penetrating poly(disulfide)s (CPD) facilitated their rapid intracellular uptake with minimal endolysosomal trapping, providing sufficient time for effective mitochondrial localization followed by glutathione-triggered biodegradation and of native, functional proteins into the mitochondria.

[1]  H. Kiyono,et al.  Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. , 2010, Nature materials.

[2]  M. Shirakawa,et al.  Pruning the ALS-associated protein SOD1 for in-cell NMR. , 2013, Journal of the American Chemical Society.

[3]  Jean-Christophe Leroux,et al.  Disulfide-containing parenteral delivery systems and their redox-biological fate. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[4]  S. Dhar,et al.  Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics , 2012, Proceedings of the National Academy of Sciences.

[5]  N. Nishiyama,et al.  Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. , 2009, Angewandte Chemie.

[6]  J. Nunnari,et al.  Mitochondria: In Sickness and in Health , 2012, Cell.

[7]  T. Panavas,et al.  Optimized Mitochondrial Targeting of Proteins Encoded by Modified mRNAs Rescues Cells Harboring Mutations in mtATP6. , 2018, Cell reports.

[8]  S. Dhar,et al.  Targeted nanoparticles in mitochondrial medicine. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[9]  R. Corradini,et al.  Breakable Hybrid Organosilica Nanocapsules for Protein Delivery. , 2016, Angewandte Chemie.

[10]  E. Derivery,et al.  Efficient Delivery of Quantum Dots into the Cytosol of Cells Using Cell-Penetrating Poly(disulfide)s , 2017, Journal of the American Chemical Society.

[11]  Robin A. J. Smith,et al.  Mitochondria-targeted small molecule therapeutics and probes. , 2011, Antioxidants & redox signaling.

[12]  Zhan Chen,et al.  Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics. , 2017, Nanoscale.

[13]  S. Yao,et al.  Cell-Penetrating Poly(disulfide) Assisted Intracellular Delivery of Mesoporous Silica Nanoparticles for Inhibition of miR-21 Function and Detection of Subsequent Therapeutic Effects. , 2016, Angewandte Chemie.

[14]  T. Hyeon,et al.  Ceria Nanoparticle Systems for Selective Scavenging of Mitochondrial, Intracellular, and Extracellular Reactive Oxygen Species in Parkinson's Disease. , 2018, Angewandte Chemie.

[15]  V. Rotello,et al.  Promises and Pitfalls of Intracellular Delivery of Proteins , 2014, Bioconjugate chemistry.

[16]  G. Cheng,et al.  Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance. , 2017, ACS applied materials & interfaces.

[17]  Heyou Han,et al.  Precisely Striking Tumors without Adjacent Normal Tissue Damage via Mitochondria-Templated Accumulation. , 2018, ACS nano.

[18]  R. Raines,et al.  Boronate-Mediated Biologic Delivery , 2012, Journal of the American Chemical Society.

[19]  S. Kelley,et al.  Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. , 2016, Accounts of chemical research.

[20]  Qiaobing Xu,et al.  Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy. , 2014, Angewandte Chemie.

[21]  G. Weiner.  Building better monoclonal antibody-based therapeutics , 2015, Nature Reviews Cancer.

[22]  S. Yao,et al.  Intracellular Delivery of Functional Native Antibodies under Hypoxic Conditions by Using a Biodegradable Silica Nanoquencher. , 2017, Angewandte Chemie.

[23]  Matteo Fassan,et al.  A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[24]  S. Yao,et al.  Bypassing Endocytosis: Direct Cytosolic Delivery of Proteins. , 2018, Journal of the American Chemical Society.

[25]  M. Sailor,et al.  Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles. , 2015, ACS Nano.

[26]  J. Joseph,et al.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. , 2017, Chemical reviews.

[27]  K. Lim,et al.  A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models , 2014, Nature Communications.

[28]  A. Colell,et al.  Mitochondrial glutathione, a key survival antioxidant. , 2009, Antioxidants & redox signaling.

[29]  R. Capaldi,et al.  Structure and function of cytochrome c oxidase. , 1990, Annual review of biochemistry.

[30]  S. Yao,et al.  Simultaneous Imaging of Endogenous Survivin mRNA and On-Demand Drug Release in Live Cells by Using a Mesoporous Silica Nanoquencher. , 2017, Small.

[31]  Xiaohua Li,et al.  A Strategy for Specific Fluorescence Imaging of Monoamine Oxidase A in Living Cells. , 2017, Angewandte Chemie.